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Background: Medium-chain Acyl-CoA dehydrogenase deficiency (MCADD) is the most common inherited disorder
of fatty acid beta-oxidation. Signs and symptoms of MCADD typically appear during infancy or early childhood and
include vomiting, lethargy, and hypoglycemia. Pulmonary haemorrhage has previously been described in patients
with MCADD, but has always been considered a pre-terminal complication caused by heart failure.
Case presentation: We report on a newborn term infant that presented on the second day of life with signs of
encephalopathy, followed by hypovolemia and respiratory distress caused by a severe pulmonary haemorrhage. Fluid
resuscitation and mechanical ventilation were initiated and the coagulopathy was corrected by the administration of
fresh frozen plasma. Echocardiography revealed a normal cardiac function. After 6 days of full intensive care, the
patient survived without sequellae. The clinical presentation in absence of signs of infection raised a strong suspicion
for a metabolic disorder and genetic testing revealed MCADD due to a homozygous A985G mutation.
Conclusion: The key towards successful management of severe pulmonary haemorrhage in newborns with a
coagulopathy and suspicion of an underlying metabolic disorder consists of adequate mechanical ventilation and
aggressive use of fresh frozen plasma, while treating the metabolic decompensation and initiating an early diagnostic
work-up. MCADD can lead to acute decompensation and present with complications such as pulmonary haemorrhage
independent of cardiac function. Hence, in the context of MCADD, pulmonary haemorrhage should not be considered
a pre-terminal complication caused by heart failure, and rather than withdrawing care, intensive treatment must
be initiated.
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Clinically significant pulmonary haemorrhage in newborns
is rare [1]. In term infants, it is usually associated with
meconium aspiration, hypotension or resuscitation with
positive pressure ventilation, but its exact pathogenesis
remains unknown [1]. Medium-chain Acyl-CoA dehydro-
genase deficiency (MCADD) is a rare metabolic disorder
in which patients have problems breaking down fatty acids
for energy [2,3]. In a typical clinical scenario, a previously
healthy child with MCADD presents between the
ages three and 24 months with low blood sugar levels,
vomiting, and lethargy [3]. Acute episodes are generally* Correspondence: willem.staels@ugent.be
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unless otherwise stated.triggered by a common illness or by prolonged fasting
and liver disease is often seen at presentation [3]. The
prognosis of MCADD is excellent once the diagnosis is
established and frequent feedings to avoid fasting are
instituted [3].
We present a patient with MCADD who presented
with rapidly progressive respiratory symptoms due to a
massive pulmonary haemorrhage. This is, to the best of
our knowledge, the second reported surviving infant
with this presentation. In one previous report, pulmonary
haemorrhage was suggested to constitute a pre-terminal
complication caused by heart failure [4]. However, we
documented normal cardiac function and therefore
suggest that, in this patient pulmonary haemorrhage
was spontaneous and related to the coagulopathy caused
by metabolic decompensation.his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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The patient was born after an uncomplicated term
pregnancy. He weighed 3290 g, appeared vigorous
and had perfect Apgar scores. The amniotic fluid was
clear. Both parents were healthy, non-consanguineous
and there were no siblings. There was no maternal
drug abuse. On the second day of life, he presented
with poor feeding and grunting. He was lethargic but
still reactive upon stimulation and was hypothermic
(33°C). His skin was pale, with a prolonged capillary
refill time (3 sec) and he had weak femoral pulses.
His clinical condition indicated a serious illness with
signs of hypovolemic shock. A bolus of normal saline
was administered and broad-spectrum antibiotics were
initiated. Complete blood count and C-reactive protein
were normal, but he had a mild acidosis (pH 7.26) and
low blood glucose levels (24 mg/dl). After a bolus of 10%
dextrose was given, followed by a continuous infusion
glucose levels rose to 72 mg/dl. The patient was referred
to our neonatal intensive care unit (NICU).
Upon arrival of the NICU transport team (i.e. 45 minutes
after initial admission), a stuporous but arousable patient
was seen. The boy was pale and poorly perfused, had
tachycardia but still a normal blood pressure. He was
grunting, had subcostal retractions, tachypnea and
bilateral crackles on auscultation. Another fluid bolus
was given and the infant was intubated using rapid
sequence intubation. Upon intubation of the trachea, clear
red blood returned through the tube. Endotracheal
suctioning cleared a large quantity of blood after which
mechanical ventilation was initiated. There were no ma-
ternal risk factors for vitamin K deficiency and prophylaxis
with 2 milligram oral phylloquinone (Vitamin K1) had
been given directly after birth.
Upon arrival at the NICU, arterial blood gas analysis
was normalized and routine investigations showed no
signs of infection. Urea, creatinine and electrolytes
were normal; liver transaminases were equally normal,
as were alkaline phosphatase, bilirubin and albumin.Figure 1 Chest X-rays showing bilateral patchy infiltrates due to pulmThe coagulation was severely disrupted with a prolonged
prothrombin time and an international normalised ratio
of 2.64. This was corrected by administration of fresh
frozen plasma and an additional parenteral administration
of Vitamin K. The patient received packed red cells to
correct anaemia. Chest X-ray revealed bilateral patchy
pulmonary infiltrates (Figure 1).
In the following hours, the patients’ respiratory
state deteriorated. We observed a severe and progres-
sive respiratory acidosis (pH 7.11, pO2 74.9 mmHg,
pCO2 72.7 mmHg, bicarbonate 17.6 mmol/l, base
excess −8.6 mmol/l, lactate 1.5 mmol/l). Chest X-ray
revealed progression of the pulmonary infiltrates. Mechan-
ical ventilation became increasingly difficult with a need
for higher positive end-expiratory pressures (PEEP) and
peak-inspiratory pressures during synchronized intermit-
tent mandatory ventilation (SIMV). High frequency oscilla-
tion ventilation was tried, but SIMV with high PEEP (up to
10 cm H20) proved most successful. Meanwhile, repetitive
endotracheal suctioning continued to clear bloody secre-
tions from the airways. The clinical presentation was that of
a pulmonary haemorrhage. Echocardiography showed a
normal size and shape of the heart as well as a normal
cardiac function. Cranial ultrasound was normal. After
stabilization, computed tomography of the chest was per-
formed in order to identify any underlying intrathoracic le-
sion or vascular anomaly. Apart from massive pulmonary
infiltrates, no structural lesions were found. Bronchoscopy
could not identify obvious upper airway injuries. Since
cardiac function was normal and no underlying lesion
had been identified, the only clue to the origin of the
pulmonary haemorrhage was the initial coagulopathy.
The coagulopathy was compatible with a disseminated
intravascular coagulopathy since platelet count dropped
from 234,000/μl (day 2) to 183,000/μl (day 5) (reference
140,000-440,000) and fibrinogen was at its nadir 99 mg/dl
(day 2) (reference 160–415) but restored to 391 mg/dl at
day 14. Laboratory signs of infection and blood cultures
remained negative; these and other test results are shownonary hemorrhage on admission and resolution upon discharge.
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metabolic disorder was suspected and a first-line meta-
bolic workup was executed during the acute phase. The
patient quickly improved after his second day in hospital
and mechanical ventilation was continued for 6 days,
weaning was uncomplicated and on the seventh day of
life, the boy was successfully extubated. Coagulation
screens were repeatedly normal before discharge from
hospital and no other bleedings were observed.
Delayed delivery of the sample to the lab made results of
the neonatal screening (Guthrie) and the metabolic review
only available after 14 days (Table 2). The plasma
amino acid profile was normal. Tandem mass spectrometryTable 1 Laboratory data
Variable At referral from other
hospital, Day 2
On a
hosp
C-reactive protein (mg/dl) <0.1 <0.5
Haematocrit (%) 42.8 33
Haemoglobin (g/dl) 16.3 11.5
Mean corpuscular volume (μm3) 92 105.4
White-cell count (per mm3) 18.4 16.8
Platelet count (per mm3) 234000 2200
Prothrombin time (%) 27
International normalised ratio 2.64
Partial-thromboplastin time (sec) 131*
Fibrinogen (mg/dl) 99
Sodium (mmol/l) 143
Potassium (mmol/l) 4.67
Chloride (mmol/l) 106
Bicarbonate (mmol/l) 16
Calcium (mEq/l) 4.2
Glucose (mg/dl) 24 167
Creatinine (mg/dl) 0.85
Total bilirubin (mg/dl) 5.31
Protein (g/dl) 4.4
Albumin (g/dl) 3.5
Alanine aminotransferase (U/l) 29
Aspartate aminotransferase (U/l) 59
Lactate dehydrogenase (U/l) 1040
Creatine kinase (U/l) 1658
Blood gas analysis
pH 7.26 7.351
pO2 (mmHg) 147
pCO2 (mmHg) 33.2
Actual base excess (mmol/l) -6.4
Lactate (mmol/l) 1.8
*Prolonged partial-thromboplastin time might have been the consequence of hepa
without heparin 5 hours later showed a partial-thromboplastin time of 34 seconds,showed elevated levels of C6 (1.07 μmol/l, normal range
0.09-0.26), C8 (4.45 μmol/l, normal range 0.05-0.23) and
C10:1 (1.41 μmol/l, normal range 0.04-0.25) acylcarnitines,
consistent with Medium-chain Acyl-CoA dehydrogenase
deficiency (MCADD) (#MIM 201450). A urinary organic
acid profile collected on day 14 demonstrated a mild
hypoketotic dicarboxylic aciduria with increased excretion
of 5-hydroxyhexanoate (48 mmol/mol creat, reference <26)
and octanoate (7 mmol/mol creat, reference <2), but
absence of acylglycine accumulation. Urinary organic
acid profile during decompensation was not available.
Sequence analysis of the ACADM gene detected the com-
mon homozygous A985G missense mutation, confirmingdmission to this
ital, Day 2
Day 3 Day 12 Normal range
<0.5 <0.5
42 42 - 60
14.6 13,5 - 20,5
102.8 88 - 104
13.5 6.0 - 17.5
00 183000 140,000 - 440,000
51 79 60 - 100
1.58 1.04
30 35 22 - 38
113 391 160 - 415
134 139 132 - 146
4.2 4.63 3,5 - 5,0
103 94 - 110
22 22 - 29
5.3 4.3 - 5.1
163 79 70 - 115
0.39 0.24 - 0.85
15.6 1.50 - 12.00
5 5.6 4.6 - 6.8
3.6 4 2.8 - 4.4
34 <41
88 <37
240 - 480
<652
7.115 7.35 - 7.45
74.9 83 - 108
72.7 35 - 48
-8.6 -2.0 - +3.0
1.4 0.5 - 1.6
rin in the umbilical catheter when the blood sample was taken. Control sample
a normal value; INR remained prolonged 1.80 and prothrombin time was 41%.
Table 2 First line metabolic work-up
Variable Day 14 Normal range
Ammonia (μg/dl) 113 <228
Plasma amino acids Normal
Urine organic acids
Lactate (mmol/mol creat) 76 <79
3-Hydroxybutryrate (mmol/mol creat) 0 <26
Acetoacetate (mmol/mol creat) 0 <9
2-Oxoglutarate (mmol/mol creat) 942 <723
5-Hydroxyhexanoate (mmol/mol creat) 48 <26
Adipate (mmol/mol creat) 15 <30
Hexanoylglycine (mmol/mol creat) 0 <2
Octanoate (mmol/mol creat) 7 <2
Sebacate (mmol/mol creat) 20 <4
Suberate (mmol/mol creat) 20 <11
Suberglycine (mmol/mol creat) 0 <1
Acylcarnitine profile
Free carnitine (μmol/l) 27.88 17.7 – 48.8
Saturated acylcarnitines
Hexanoyl carnitine C6 (μmol/l) 1.07 0.09 - 0.26
Octanoyl carnitine C8 (μmol/l) 4.45 0.05 - 0.23
Decanoyl carnitine C10 (μmol/l) 0.48 0.06 - 0.31
Unsaturated acylcarnitines
Decanoyl C10:1 (μmol/l) 1.41 0.04 – 0.25
Dodecanoyl C12:1 (μmol/l) 0.05 n.d. - 0.20
Table 2. Results from basic metabolic investigations.
Interpretation urine organic acids: Mild hypoketotic dicarboxyluria.
Increased excretion of 5-hydroxyhexanoate and octanoate, absense of suspect
glycine conjugates (suberylglycine and hexanoylglycine). Normal ratio of
adipine, suberine and sebacine acid.
Conclusion: Mildly disturbed profile, not diagnostic. Differential diagnosis includes
mild physiologic dicarboxylaciduria in children under 6 months, MCT diet or
MCAD deficiency. To be correlated with clinical presentation and
acylcarnitine profile.
Interpretation acylcarnitine profile: Raised C6, C8, C10, C10:1 and C12:1.
Conclusion: Disturbed profile compatible with MCAD deficiency.
Staels et al. Maternal Health, Neonatology, and Perinatology  (2015) 1:8 Page 4 of 6the diagnosis. Carnitine supplementation was initiated and
avoidance of fasting through frequent feeding was advised.
A schematic representation of the clinical course is
reported in Figure 2. At the age of 36 months, the infant
remains well with normal growth and development.
Discussion
Clinically significant pulmonary haemorrhage in newborns
occurs at a rate of 1 to 12 per 1000 live births, and in term
infants is usually associated with meconium aspiration,
hypotension or resuscitation with positive pressure ventila-
tion [1]. The exact pathogenesis of pulmonary haemor-
rhage remains unknown, although several theories
have been suggested. In most cases of neonatal pul-
monary haemorrhage, the lung effluent is thought to behaemorrhagic edema rather than blood [1]. Berger et al.
speculate that in near-term or term infants suffering
from intrauterine hypoxia, pulmonary hypertension and
myocardial dysfunction might elevate pulmonary capil-
lary pressure, causing stress failure and intra-alveolar
haemorrhage [1].
Medium-chain Acyl-CoA dehydrogenase deficiency
(MCADD) is the most common inherited disorder of
mitochondrial fatty acid beta-oxidation. The overall
frequency of the disorder is highest in northern Europe
and has been estimated to range between 1:4,900 and
1:17,000 [2,3]. Fatty acid beta-oxidation fuels hepatic
ketogenesis, a major source of energy once hepatic
glycogen stores become depleted [3]. In a typical
clinical scenario, a previously healthy child with MCADD
presents between the third month and the second year of
life with hypoketotic hypoglycaemia, vomiting, and
lethargy, which can quickly progress to coma and
death [3]. Acute episodes are generally triggered by a
common illness or by prolonged fasting and liver disease
is often seen at presentation. The prognosis of MCADD is
excellent once the diagnosis is established and frequent
feedings are instituted [3].
The patient presented in this case report probably
developed hypoglycaemia and encephalopathy on the
second day of life, resulting in inadequate feeding and
further deterioration of his neurological condition. These
initial signs of metabolic decompensation are often subtle
and the rapidly progressive respiratory symptoms quickly
dominated the clinical presentation, imposing the need
for mechanical ventilation. Sepsis was the initial working
diagnosis, but the absence of infectious signs together
with a severe coagulopathy and a subsequent massive
pulmonary haemorrhage raised suspicion towards an
underlying metabolic disorder. So far, pulmonary haemor-
rhage in MCADD has only been reported in four post-
mortem [5] and one surviving case [4]. In the latter,
pulmonary haemorrhage was suggested to result from a
transient, post-asphyxial cardiomyopathy, documented
by cardiac ultrasound examination [4]. Although the
clinical course was overall identical in our patient,
cardiac function was repeatedly found to be normal.
In contrast, both the patient presented by Maclean
et al. and our patient were in an anticoagulated state.
One obvious explanation could be liver dysfunction
which is commonly seen in MCADD as a conse-
quence of microvesicular hepatic steatosis due to the
accumulation of medium chain fatty acids and sec-
ondary hepatocellular dysfunction [6]. However, trans-
aminases were not elevated and the exact underlying
mechanism of the coagulopathy remains uncertain.
Indeed, the role of coagulopathy in pulmonary haemor-
rhage of any origin remains obscure, many studies have
implicated activation of inflammation and derangement of
Figure 2 Timeline showing work-up to diagnosis of MCADD. ACADM: acyl-CoA dehydrogenase, C-4 to C-12 straight chain (MIM:607008), ALT:
Alanine transaminase, AST: Aspartate transaminase, CK: Creatine kinase, CRP: C-reactive protein, PH: pulmonary haemorrhage.
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acute lung injury or acute respiratory distress syndrome
[7]. The clinical presentation with respiratory distress
makes a spontaneous onset of the pulmonary haemor-
rhage triggered by metabolic decompensation prob-
able. However, pulmonary haemorrhage may also have
been aggravated by positive pressure ventilation during
resuscitation.
Conclusion
This is, to our knowledge, the second case reported in
which a clinically significant pulmonary haemorrhage
has been described in a surviving newborn infant with
MCADD. In the only other surviving infant reported so
far, pulmonary haemorrhage has been suggested to be a
pre-terminal complication caused by heart failure. The
key towards successful management of severe pulmonary
haemorrhage in newborns with a coagulopathy and
suspicion of an underlying metabolic disorder consists
of adequate mechanical ventilation, aggressive use of
fresh frozen plasma, while treating the metabolic
decompensation by reversing catabolism and sustaining
anabolism and initiating an early diagnostic work-up.
We believe that in patients with MCADD, metabolic
decompensation can cause a severe coagulopathy and
a pulmonary haemorrhage, independent of cardiac func-
tion. Hence, pulmonary haemorrhage should not be
considered a pre-terminal complication caused by heart
failure, and rather than withdrawing care, intensive
treatment must be initiated.Consent
Written informed consent was obtained from the patient
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